title: Delivery of a normal newborn after intensive medical treatment for an acute exacerbation of ulcerative colitis during pregnancy: a case report.
abstract: A 28-year-old woman developed an acute exacerbation of chronic ulcerative colitis in the second trimester of pregnancy. She was treated by intensive medical treatment with intravenous prednisolone, betamethasone enema, oral salazosulfapyridine, intravenous ceftazitim, and total parenteral nutrition. The acute relapse subsided after 73 days of the treatment and a normal female newborn weighing 2,208 g was delivered vaginally after 40 weeks' gestation. Our experience showed that the intensive medical therapy did not impair either the course of the pregnancy or the fetal outcome.
authors.affiliation: Department of Surgery II, Mie University Medical School, Tsu, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Ishijima
authors.forename: E
authors.initials: E
authors.lastname: Ojima
authors.forename: H
authors.initials: H
authors.lastname: Tonouchi
authors.forename: H
authors.initials: H
authors.lastname: Suzuki
authors.forename: S
authors.initials: S
authors.lastname: Fukunishi
mesh_terms: D000328:Adult; D001623:Betamethasone / Q000008:administration & dosage; D003093:Colitis, Ulcerative / Q000175:diagnosis / Q000628:therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D010288:Parenteral Nutrition; D011239:Prednisolone / Q000008:administration & dosage; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000628:therapy*; D011256:Pregnancy Outcome; D011263:Pregnancy Trimester, Third; D012812:Sigmoidoscopy; D012460:Sulfasalazine / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D012460:Sulfasalazine; D001623:Betamethasone; D011239:Prednisolone